Clinical Utility of Comprehensive Liquid Molecular Profiling in Patients With Advanced Endometrial Cancer
(Abstracted from Cancer 2024;130(19):3311–3320) Endometrial cancer (EC) has been increasing in incidence and mortality rates due to increased prevalence of risk factors such as obesity, metabolic syndrome, and diabetes. Many cases are treatable through a combination of methods, but up to 20% of cases are detected at an advanced stage, which has a grim prognosis.
Authors
- Judith Michels (ORCID: https://orcid.org/0000-0002-9640-0222)
- Ludovic Lacroix (ORCID: https://orcid.org/0000-0003-2535-1010)
- Félix Blanc‐Durand (ORCID: https://orcid.org/0000-0002-5277-1515)
- Kaïssa Ouali (ORCID: https://orcid.org/0000-0002-8269-3001)
- Etienne Rouleau (ORCID: https://orcid.org/0000-0002-6316-5668)
- Maud Ngo‐Camus (ORCID: https://orcid.org/0009-0005-1370-4458)
- Claudio Nicotra (ORCID: https://orcid.org/0009-0004-4662-3753)
- Santiago Ponce-Aix (ORCID: https://orcid.org/0000-0002-2289-4709)
- Mihaela D. Aldea (ORCID: https://orcid.org/0000-0001-7685-051X)
- Antoîne Italiano (ORCID: https://orcid.org/0000-0002-8540-5351)
- Arnaud Bayle
- Damien Vasseur (ORCID: https://orcid.org/0000-0001-8787-1498)
- Géraldine M. Camilleri
- Patricia Pautier (ORCID: https://orcid.org/0000-0001-9904-3040)
- Alexandra Leary
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/01.ogx.0001108092.35846.d7
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00